Long-term maternal morbidity and mortality associated with ischemic placental disease

Seminars in Perinatology

Volumn 38, Issue 3, 2014, Pages 146-150

  Adams, Tracy ^a   Yeh, Corinne ^a   Bennett Kunzier, Nadia ^a   Kinzler, Wendy L ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Fetal growth restriction; Ischemic placental disease; Long term maternal morbidity; Placental abruption; Preeclampsia

Indexed keywords

CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; FEMALE; HEALTH HAZARD; HUMAN; HYPERTENSION; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; ISCHEMIC PLACENTAL DISEASE; MATERNAL MORBIDITY; MATERNAL MORTALITY; METABOLIC SYNDROME X; PATIENT COUNSELING; PLACENTA DISORDER; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SOLUTIO PLACENTAE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CHRONIC DISEASE; COMPLICATION; ISCHEMIA; MORTALITY; MOTHER; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VASCULARIZATION;

ABRUPTIO PLACENTAE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CHRONIC DISEASE; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYPERTENSION; ISCHEMIA; MATERNAL MORTALITY; METABOLIC SYNDROME X; MOTHERS; PLACENTA; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84900404874     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2014.03.003     Document Type: Review

References (34)

1. Ananth C.V., Vintzileos A.M. Ischemic placental disease: epidemiology and risk factors. Eur J Obstet Gynecol Reprod Biol 2011, 159(1):77-82.
2. Ananth C.V., Peltier M.R., Chavez M.R., Kirby R.S., Getahun D., Vintzileos A.M. Recurrence of ischemic placental disease. Obstet Gynecol 2007, 110(1):128-133.
3. Albareda M., Caballero A., Badell G., et al. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 2003, 26(4):1199-1205.
4. Heidrich M.B., Wenzel D., von Kaisenberg C.S., Schippert C., vonVersen-Hoynck F.M. Preeclampsia and long-term risk of cardiovascular disease: what do obstetrician-gynecologists know?. BMC Pregnancy Childbirth 2013, 13:61.
5. Nijdam M.E., Timmerman M.R., Franx A., et al. Cardiovascular risk factor assessment after pre-eclampsia in primary care. BMC Fam Pract 2009, 10:77.
6. Adams E.M., Macgillivray I. Long-term effect of preeclampsia on blood-pressure. Lancet 1961, 2(7217):1373-1375.
7. Wilson B.J., Watson M.S., Prescott G.J., et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. Br Med J 2003, 326(7394):845.
8. Bellamy L., Casas J.P., Hingorani A.D., Williams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Br Med J 2007, 335(7627):974.
9. Harskamp R.E., Zeeman G.G. Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci 2007, 334(4):291-295.
10. Lykke J.A., Langhoff-Roos J., Sibai B.M., Funai E.F., Triche E.W., Paidas M.J. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009, 53(6):944-951.
11. McDonald S.D., Ray J., Teo K., et al. Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia. Atherosclerosis 2013, 229(1):234-239.
12. Forest J.C., Girouard J., Masse J., et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005, 105(6):1373-1380.
13. Fraser A., Nelson S.M., Macdonald-Wallis C., et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 2012, 125(11):1367-1380.
14. Sandvik M.K., Leirgul E., Nygard O., et al. Preeclampsia in healthy women and endothelial dysfunction 10 years later. Am J Obstet Gynecol 2013.
15. Ostlund E., Al-Nashi M., Hamad R.R., et al. Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia. Hypertens Res 2013, 36(12):1081-1087.
16. Ray J.G., Schull M.J., Kingdom J.C., Vermeulen M.J. Heart failure and dysrhythmias after maternal placental syndromes: HAD MPS Study. Heart 2012, 98(15):1136-1141.
17. Mongraw-Chaffin M.L., Cirillo P.M., Cohn B.A. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 2010, 56(1):166-171.
18. Irgens H.U., Reisaeter L., Irgens L.M., Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J 2001, 323(7323):1213-1217.
19. Funai E.F., Friedlander Y., Paltiel O., et al. Long-term mortality after preeclampsia. Epidemiology 2005, 16(2):206-215.
20. Hermes W., Koopmans C.M., van Pampus M.G., et al. Induction of labour or expectant monitoring in hypertensive pregnancy disorders at term: do women's postpartum cardiovascular risk factors differ between the two strategies?. Eur J Obstet Gynecol Reprod Biol 2013, 171(1):30-34.
21. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG 2007, 114(3):300-309. Magpie Trial Follow-Up Study Collaborative Group.
22. Tang C.H., Wu C.S., Lee T.H., et al. Preeclampsia-eclampsia and the risk of stroke among peripartum in Taiwan. Stroke 2009, 40(4):1162-1168.
23. Aukes A.M., De Groot J.C., Wiegman M.J., Aarnoudse J.G., Sanwikarja G.S., Zeeman G.G. Long-term cerebral imaging after pre-eclampsia. BJOG 2012, 119(9):1117-1122.
24. Habli M., Eftekhari N., Wiebracht E., et al. Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Am J Obstet Gynecol 2009, 201(4):385 e381-385.
25. Gaugler-Senden I.P., Duivenvoorden H.J., Filius A., De Groot C.J., Steegers E.A., Passchier J. Maternal psychosocial outcome after early onset preeclampsia and preterm birth. J Matern Fetal Neonatal Med 2012, 25(3):272-276.
26. Smith G.D., Sterne J., Tynelius P., Lawlor D.A., Rasmussen F. Birth weight of offspring and subsequent cardiovascular mortality of the parents. Epidemiology 2005, 16(4):563-569.
27. Smith G.C., Pell J.P., Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001, 357(9273):2002-2006.
28. Manten G.T., Sikkema M.J., Voorbij H.A., Visser G.H., Bruinse H.W., Franz A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy 2007, 26(1):39-50.
29. King T.F., Bergin D.A., Kent E.M., et al. Endothelial progenitor cells in mothers of low-birthweight infants: a link between defective placental vascularization and increased cardiovascular risk?. J Clin Endocrinol Metab 2013, 98(1):E33-E39.
30. Pariente G., Shoham-Vardi I., Kessous R., et al. Placental abruption as a significant risk factor for long-term cardiovascular mortality in a follow-up period of more than a decade. Paediatr Perinat Epidemiol 2014, 28(1):32-38.
31. Ray J.G., Vermeulen M.J., Schull M.J., Redelmeier D.A. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005, 366(9499):1797-1803.
32. Veerbeek J.H., Smit J.G., Koster M.P., et al. Maternal cardiovascular risk profile after placental abruption. Hypertension 2013, 61(6):1297-1301.
33. Ananth C.V., Vintzileos A.M. Medically indicated preterm birth: recognizing the importance of the problem. Clin Perinatol 2008, 35(1):53-67. [viii].
34. Ananth C.V., Lawrence Cleary K. Pre-eclampsia and cardiovascular disease: more questions than answers?. BJOG 2013, 120(8):920-923.